Exploring the next frontier of private markets.
First Look introduces licensed broker-dealers to distinctive investment interests, emerging opportunities, and innovative capital structures. Our goal is simple: share new ideas, explore possibilities, and start conversations about the future of investment.
Amynas
Advancing a new standard in bioresorbable implant technology.
Amynas is a medical-device company developing a fully bioresorbable envelope of drug-coated electrospun nanofibers for implanted devices. The technology is designed to improve healing, reduce complications, and eliminate the need for permanent implants.
Experienced medical-device and materials-science team; names to be confirmed.
United States; precise location to be confirmed.
Not independently verified; request current company materials.
Indicative $30 million growth financing; terms subject to confirmation.
Commercialize a proprietary bioresorbable implant platform across potential therapeutic applications.
Drug-coated nanofiber envelope designed for controlled delivery and bioresorption.
No opportunities match your search.
About First Look
First Look presents selected private-market companies and emerging opportunities for professional discussion. Explore company profiles, request further information, and arrange a conversation with the team.
